Article
Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants.
Schizophrenia research - 1 Jan 2008
Ellingrod Vicki L, Miller Del D, Taylor Stephan F, Moline Jessica, Holman Timothy, Kerr Jane
Abstract excerpt
INTRODUCTION: The metabolic syndrome and insulin resistance represent growing concerns related to atypical antipsychotic (AAP) use as their incidence in the schizophrenia population is two-to-four-fold higher than the general population. Reduced methylenetetrahydrofolate reductase (MTHFR) activity, resulting in aberrant folate metabolism and hyperhomocysteinemia, has been linked to cardiovascular disease and is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.